ASGE Annual GI Advanced Practice Provider Course (On-Demand) - Clinical Case-Based Learning (Day Two) | April 2023-Questions and Answers: Session 6

Video Transcription

Video Summary

In this video, the panelists address questions related to the antibiotic management of small intestinal bacterial overgrowth (SIBO). They discuss the challenges of getting third-party payers to cover the cost of rifaximin, the recommended antibiotic for SIBO. They also mention the shortage of neomycin, another antibiotic used for SIBO. The panelists suggest alternatives such as metronidazole and herbal products. They emphasize the importance of ruling out other conditions and treating functional bowel disorders before focusing on SIBO. They also mention the need for shared decision-making with patients and considering the efficacy and potential side effects of antibiotic treatment. The video also touches on topics such as surveillance for Barrett's esophagus and gastric intestinal metaplasia, and the use of proton pump inhibitors (PPIs) for GERD. Overall, the panelists provide insights into the management of these conditions and discuss the use of antibiotics and other treatment options. (No credits granted)

Keywords

SIBO

antibiotic management

rifaximin

neomycin shortage

treatment options